Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-27 · accession 0001209191-23-014078 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-01 | 2023-02-27 | KPTI | Mason Michael | EVP, CFO, Treas | S - Sale | $3.04 | -2,802 | 161.6K | -2% | -$8,518 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-27 | S | D | 2,802 | $3.04 | 161,566 | D | — | — |